Share

    


Home / Search Results

Search Results

You searched for:

Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.
Discover how 2017 ACCC Innovator Award winner Advocate Medical Group developed and implemented an immunotherapy program, lessons learned, and tools created to educate staff and patients.
While young people across the U.S. are able to access more information through technology with greater speed, they may be misinformed or lack understanding of how unhealthy behaviors can put their health at risk.
The only standard treatments for metastatic melanoma that have been associated with long-term overall survival (OS) are surgical resection, and immunotherapies that include the immune-stimulating cytokine interleukin-2 (IL2), the anticytotoxic T lymphocyte antigen-4 (CTLA-4) monoclonal antibody ipilimumab, and the anti-programmed death 1 (PD1) monoclonal antibodies nivolumab and pembrolizumab (aka …
Estheticians and other salon professionals are in a unique position to take note of unusual growths on their client’s skin and initiate an important conversation that may ultimately save a patient’s life.